MedPath

University of Helsinki

University of Helsinki logo
🇫🇮Finland
Ownership
Private
Established
1640-01-01
Employees
-
Market Cap
-
Website
http://www.helsinki.fi

Drug Sensitivity Testing Personalizes AML Treatment and Improves Outcomes

A Finnish study demonstrates that drug sensitivity testing can identify acute myeloid leukemia (AML) patients likely to benefit from venetoclax and azacitidine, improving treatment outcomes.

© Copyright 2025. All Rights Reserved by MedPath